New York State Common Retirement Fund’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,800
| Closed | -$16K | – | 3261 |
|
|
2025
Q1 | $16K | Hold |
9,800
| – | – | ﹤0.01% | 3013 |
|
|
2024
Q4 | $17.9K | Hold |
9,800
| – | – | ﹤0.01% | 3058 |
|
|
2024
Q3 | $56.1K | Sell |
9,800
-3,100
| -24% | -$25.6K | ﹤0.01% | 2822 |
|
|
2024
Q2 | $104K | Buy |
+12,900
| New | +$136K | ﹤0.01% | 2754 |
|
|
2023
Q3 | – | Sell |
-136
| Closed | -$726 | – | 3319 |
|
|
2023
Q2 | $726 | Sell |
136
-4,091
| -97% | -$33K | ﹤0.01% | 3335 |
|
|
2023
Q1 | $41.6K | Sell |
4,227
-7,192
| -63% | -$123K | ﹤0.01% | 3025 |
|
|
2022
Q4 | $214K | Buy |
11,419
+22
| +0.2% | +$499 | ﹤0.01% | 2698 |
|
|
2022
Q3 | $236K | Buy |
11,397
+29
| +0.3% | +$742 | ﹤0.01% | 2696 |
|
|
2022
Q2 | $236K | Sell |
11,368
-26
| -0.2% | -$733 | ﹤0.01% | 2720 |
|
|
2022
Q1 | $491K | Buy |
11,394
+11
| +0.1% | +$496 | ﹤0.01% | 2412 |
|
|
2021
Q4 | $682K | Sell |
11,383
-36
| -0.3% | -$2.88K | ﹤0.01% | 2278 |
|
|
2021
Q3 | $981K | Sell |
11,419
-3,464
| -23% | -$348K | ﹤0.01% | 2120 |
|
|
2021
Q2 | $1.66M | Buy |
14,883
+2,125
| +17% | +$204K | ﹤0.01% | 1984 |
|
|
2021
Q1 | $1.42M | Buy |
12,758
+933
| +8% | +$123K | ﹤0.01% | 1966 |
|
|
2020
Q4 | $1.26M | Hold |
11,825
| – | – | ﹤0.01% | 1935 |
|
|
2020
Q3 | $1.65M | Buy |
11,825
+842
| +8% | +$176K | ﹤0.01% | 1671 |
|
|
2020
Q2 | $3.55M | Buy |
10,983
+5,575
| +103% | +$895K | ﹤0.01% | 1293 |
|
|
2020
Q1 | $483K | Hold |
5,408
| – | – | ﹤0.01% | 2058 |
|
|
2019
Q4 | $214K | Hold |
5,408
| – | – | ﹤0.01% | 2714 |
|
|
2019
Q3 | $133K | Hold |
5,408
| – | – | ﹤0.01% | 2947 |
|
|
2019
Q2 | $191K | Hold |
5,408
| – | – | ﹤0.01% | 2838 |
|
|
2019
Q1 | $242K | Hold |
5,408
| – | – | ﹤0.01% | 2634 |
|
|
2018
Q4 | $260K | Sell |
5,408
-1,575
| -23% | -$95.7K | ﹤0.01% | 2585 |
|
|
2018
Q3 | $466K | Sell |
6,983
-917
| -12% | -$51.1K | ﹤0.01% | 2443 |
|
|
2018
Q2 | $372K | Sell |
7,900
-4,287
| -35% | -$236K | ﹤0.01% | 2589 |
|
|
2018
Q1 | $689K | Buy |
12,187
+1,525
| +14% | +$82.5K | ﹤0.01% | 2216 |
|
|
2017
Q4 | $528K | Hold |
10,662
| – | – | ﹤0.01% | 2329 |
|
|
2017
Q3 | $811K | Buy |
10,662
+1,556
| +17% | +$116K | ﹤0.01% | 2107 |
|
|
2017
Q2 | $857K | Sell |
9,106
-11,601
| -56% | -$992K | ﹤0.01% | 2134 |
|
|
2017
Q1 | $1.65M | Buy |
20,707
+1,502
| +8% | +$120K | ﹤0.01% | 1777 |
|
|
2016
Q4 | $1.6M | Hold |
19,205
| – | – | ﹤0.01% | 1820 |
|
|
2016
Q3 | $2.15M | Buy |
19,205
+4,719
| +33% | +$521K | ﹤0.01% | 1610 |
|
|
2016
Q2 | $1.61M | Sell |
14,486
-12,005
| -45% | -$1.46M | ﹤0.01% | 1721 |
|
|
2016
Q1 | $2.77M | Sell |
26,491
-6,639
| -20% | -$513K | ﹤0.01% | 1457 |
|
|
2015
Q4 | $2.67M | Hold |
33,130
| – | – | ﹤0.01% | 1483 |
|
|
2015
Q3 | $2.3M | Buy |
33,130
+1,220
| +4% | +$106K | ﹤0.01% | 1539 |
|
|
2015
Q2 | $3.13M | Buy |
31,910
+15,947
| +100% | +$1.7M | ﹤0.01% | 1622 |
|
|
2015
Q1 | $1.56M | Buy |
15,963
+3,900
| +32% | +$378K | ﹤0.01% | 1726 |
|
|
2014
Q4 | $1.33M | Buy |
12,063
+6,769
| +128% | +$827K | ﹤0.01% | 1756 |
|
|
2014
Q3 | $626K | Buy |
+5,294
| New | +$660K | ﹤0.01% | 1948 |
|
Other funds holding INO
DTC
New York State Common Retirement Fund's INO Position: Q2 2025 in Review
New York State Common Retirement Fund sold out of Inovio Pharmaceuticals (INO) in Q2 2025, closing a stake of 9,800 shares — an estimated $16K sold.
New York State Common Retirement Fund first reported a position in INO in Q3 2014 and held it in 40 quarters. The position peaked at $3.55M in Q2 2020. 103 funds tracked by Wall St. Rank hold INO as of Q2 2025.
- New York State Common Retirement Fund reported no remaining Inovio Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- New York State Common Retirement Fund sold 9,800 Inovio Pharmaceuticals shares in Q2 2025, an estimated $16K.
- New York State Common Retirement Fund first reported a position in Inovio Pharmaceuticals in Q3 2014 and held it in 40 quarters.
- New York State Common Retirement Fund's Inovio Pharmaceuticals position peaked at $3.55M in Q2 2020.
- 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2025.
Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.